TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
Nature, Published online: 27 March 2024; doi:10.1038/s41586-024-07233-2Anti-TRBC1 antibody–drug conjugates may offer a more potent T cell cancer therapy by bypassing the fratricide that may be limiting the efficacy of anti-TRBC1 CAR T …